Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Ascent Industries Reports Second Quarter 2026 Results; Year-Over-Year Net Sales Increase 37.6% and Adjusted EBITDA Improves by $1.8 Million

businesswire.com

Ascent Industries Reports Second Quarter 2026 Results; Year-Over-Year Net Sales Increase 37.6% and Adjusted EBITDA Improves by $1.8 Million SCHAUMBURG, Ill.--( BUSINESS WIRE)--Ascent Industries Co. (Nasdaq: ACNT) (“Ascent” or the “Company”), a specialty chemicals platform delivering differentiated, performance-driven chemical solutions, is reporting its results for the second quarter ended June 30, 2026.

Second Quarter 2026 Summary 1

(in millions, except per share and margin)

Q2 2026

Q2 2025

Change

Net Sales

$25.7

$18.7

37.6%

Gross Profit

$5.5

$4.9

14.0%

Gross Profit Margin

21.6%

26.1%

-447bps

Net Income (Loss)

$0.7

$(2.4)

127.4%

Diluted Income (Loss) per Share

$0.07

$(0.25)

129.3%

Adjusted EBITDA

$1.5

$(0.3)

+$1.8M

Adjusted EBITDA Margin

5.7%

(1.8)%

+745bps

1On May 4, 2026, the Company closed on a transaction to acquire substantially all of the assets of Midwest Graphic Sales, Inc and Sigma Coatings, Inc. (together "Midwest"). The second quarter of 2026 included $1.9 million in net sales, no net income and $0.3 million in Adjusted EBITDA from the acquisition of Midwest.

Management Commentary

“The second quarter was one of the strongest in our recent history, reflecting continued improvement across the business,” said J. Bryan Kitchen, President and Chief Executive Officer of Ascent Industries Co. “Sequentially, legacy net sales increased approximately 22% and gross margin expanded approximately 710 basis points, while volume, average selling price, gross profit and Adjusted EBITDA also improved. Despite a specialty chemicals market that remains soft, year over year net sales increased approximately 28%, total gross profit increased 14%, and Adjusted EBITDA improved by $1.8 million. On a trailing-twelve-month basis, the company saw record highs for volume, net sales, gross profit and Adjusted EBITDA from Continuing Operations.”

"The sequential improvement in gross margin demonstrates that our optimization initiatives are beginning to translate growth into stronger earnings," Kitchen added. "Although gross margin remains below both the prior-year level and our long-term expectations, our priorities remain unchanged. Commercial execution is creating profitable growth opportunities, while our operations teams apply the same standardize, simplify and optimize playbook that transformed our operating foundation over the past two years. Growth creates the opportunity. Optimization converts that opportunity into earnings. As reported last quarter, our platform-wide optimization initiative remains on track to achieve a run-rate improvement of approximately $3 million to $5 million in annualized gross profit improvement by the end of 2026. As we continue to grow, each operational improvement expands the earnings power of the platform and compounds long-term shareholder returns."

“The successful integration of the Midwest Graphic Sales acquisition further reinforces our disciplined acquisition strategy,” Kitchen continued. “In the first two months since we closed, the business performed in line with our expectations, positively contributing to gross profit and Adjusted EBITDA. Back-office integration was completed a full quarter ahead of our original commitment, the manufacturing transition remains on schedule, and our teams are already developing opportunities beyond the original underwriting case. We are building a combined business that is more capable and more valuable than either company could have become independently.”

Kitchen concluded, “Our strategy remains unchanged. What has changed is the evidence that it is delivering the outcomes we envisioned. Over the past two years, we have systematically improved the quality of our portfolio, strengthened our commercial execution, enhanced our operational excellence and applied disciplined capital allocation. Together, these capabilities are reinforcing one another, creating a higher-quality business capable of delivering consistent growth, higher returns on invested capital and greater long-term shareholder value across market cycles.”

Second Quarter 2026 Financial Results

Net sales from continuing operations were $25.7 million compared to $18.7 million in the second quarter of 2025. The increase was a result of increases in volume and average selling prices.

Gross profit from continuing operations increased 14.0% to $5.5 million, or 21.6% of net sales, compared to $4.9 million, or 26.1% of net sales, in the second quarter of 2025. The increase in dollars was primarily driven by increases in cost recovery in the period due to increased production, reductions in utilities, and repairs and maintenance partially offset by increases in labor and overhead.

Net income from continuing operations increased to $0.7 million compared to a net loss of ($2.4) million in the second quarter of 2025. Diluted earnings per share increased to $0.07 in the second quarter of 2026 compared to a diluted loss per share of ($0.25) in the second quarter of 2025.

Adjusted EBITDA from continuing operations increased to $1.5 million in the second quarter of 2026, with adjusted EBITDA margin increasing to 5.7% compared to (1.8)% in the prior year period. The increase was primarily driven by the aforementioned increase in gross profit as well as reductions in SG&A in the current year.

Liquidity

As of June 30, 2026, the Company had $28.1 million in cash and cash equivalents, no debt outstanding under its revolving credit facilities and had $17.9 million in availability under its revolving credit facility.

For the quarter ended June 30, 2026, the Company repurchased 209,868 shares at an average cost of $13.80 per share for approximately $2.9 million.

Conference Call

Ascent will hold a conference call today at 5:00 p.m. Eastern time to discuss its financial results for the second quarter ended June 30, 2026.

Ascent management will host the conference call, followed by a question-and-answer period.

Date: Tuesday, August 4, 2026

Time: 5:00 p.m. Eastern time

Live Call Registration Link: Here

Webcast Registration Link: Here

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Investor Relations at 1-630-884-9181.

The conference call will also be broadcast live and available for replay via the webcast registration link above. The webcast will be archived for one year in the investor relations section of the Company’s website at www.ascentco.com.

About Ascent Industries Co.

Ascent Industries Co. (Nasdaq: ACNT) is a specialty chemicals platform delivering differentiated, performance-driven chemical solutions. For more information about Ascent, please visit its website at www.ascentco.com.

Forward-Looking Statements

This press release may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable federal securities laws. All statements that are not historical facts are forward-looking statements. Forward looking statements can be identified through the use of words such as "estimate," "project," "intend," "expect," "believe," "should," "anticipate," "hope," "optimistic," "plan," "outlook," "should," "could," "may" and similar expressions. The forward-looking statements are subject to certain risks and uncertainties which could cause actual results to differ materially from historical results or those anticipated. Readers are cautioned not to place undue reliance on these forward-looking statements and to review the risks as set forth in more detail in Ascent Industries Co.’s Securities and Exchange Commission filings, including our Annual Report on Form 10-K, which filings are available from the SEC or on our website. Ascent Industries Co. assumes no obligation to update any forward-looking information included in this release.

Non-GAAP Financial Information

Financial statement information included in this earnings release includes non-GAAP (Generally Accepted Accounting Principles) measures and should be read along with the accompanying tables which provide a reconciliation of non-GAAP measures to GAAP measures.

We define "EBITDA" as earnings before interest, income taxes, depreciation and amortization. We define "Adjusted EBITDA" as EBITDA further adjusted for the impact of non-cash and other items we do not consider in our evaluation of ongoing performance. These items include: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, shelf registration costs, loss on extinguishment of debt, retention costs and restructuring and severance costs from net income. We caution investors that amounts presented in accordance with our definitions of EBITDA and Adjusted EBITDA may not be comparable to similar measures disclosed by other companies because not all companies calculate EBITDA and Adjusted EBITDA in the same manner. We present EBITDA and Adjusted EBITDA because we consider them to be important supplemental measures of our performance and investors' understanding of our performance is enhanced by including these non-GAAP financial measures as a reasonable basis for comparing our ongoing results of operations.

Ascent Industries Co.

Condensed Consolidated Balance Sheets

(in thousands, except par value and share data)

(Unaudited)

June 30, 2026

December 31, 2025

Assets

Current assets:

Cash and cash equivalents

$

28,069

$

57,606

Accounts receivable, net of allowance for credit losses of $119 and $1,004, respectively

18,642

10,040

Advances and other receivables

5,406

5,389

Inventories

10,488

8,742

Prepaid expenses and other current assets

2,115

1,243

Total current assets

64,720

83,020

Property, plant and equipment, net

15,693

15,762

Right-of-use assets, operating leases, net

9,074

9,368

Goodwill

4,735

Intangible assets, net

10,008

2,833

Deferred income taxes

279

Deferred charges, net

301

401

Other non-current assets, net

1,506

553

Total assets

$

106,316

$

111,937

Liabilities and Shareholders' Equity

Current liabilities:

Accounts payable

$

9,125

$

5,490

Accrued expenses and other current liabilities

3,689

5,389

Deferred revenue

34

Current portion of note payable

997

433

Current portion of operating lease liabilities

754

712

Current portion of finance lease liabilities

340

331

Total current liabilities

14,939

12,355

Long-term portion of operating lease liabilities

11,105

11,496

Long-term portion of finance lease liabilities

635

808

Deferred income taxes

241

Other long-term liabilities

41

45

Total non-current liabilities

11,781

12,590

Total liabilities

$

26,720

$

24,945

Commitments and contingencies

Shareholders' equity:

Common stock, par value $1 per share; 24,000,000 shares authorized; 9,009,453 and 9,400,898 shares outstanding as of June 30, 2026 and December 31, 2025, respectively

$

11,085

$

11,085

Capital in excess of par value

47,791

48,276

Retained earnings

44,476

45,786

103,352

105,147

Less: cost of common stock in treasury - 2,075,650 and 1,684,205 shares, respectively

(23,756

)

(18,155

)

Total shareholders' equity

79,596

86,992

Total liabilities and shareholders' equity

$

106,316

$

111,937

Note: The condensed consolidated balance sheets at December 31, 2025 have been derived from the audited consolidated financial statements at that date.

Ascent Industries Co.

Condensed Consolidated Statements of Income (Loss)

($ in thousands, except per share data)

(Unaudited)

(Unaudited)

Three Months Ended

June 30,

Six Months Ended

June 30,

2026

2025

2026

2025

Net sales

$

25,667

$

18,652

$

45,083

$

36,486

Cost of sales

20,119

13,786

36,723

28,553

Gross profit

5,548

4,866

8,360

7,933

Selling, general and administrative

5,527

6,444

10,650

11,315

Research and development

107

170

Acquisition costs and other

176

31

177

268

Asset impairments

1,622

1,622

Gain on lease modification

(544

)

(544

)

Operating loss from continuing operations

(262

)

(2,687

)

(2,637

)

(4,728

)

Other expense (income)

Interest (income) expense, net

(155

)

(15

)

(448

)

99

Other, net

(176

)

(136

)

(392

)

(285

)

Income (loss) from continuing operations before income taxes

69

(2,536

)

(1,797

)

(4,542

)

Income tax benefit

(601

)

(89

)

(487

)

(89

)

Income (loss) from continuing operations

670

(2,447

)

(1,310

)

(4,453

)

Income from discontinued operations, net of tax

8,733

8,446

Net income (loss)

$

670

$

6,286

$

(1,310

)

$

3,993

Net income (loss) per common share from continuing operations:

Basic

$

0.07

$

(0.25

)

$

(0.14

)

$

(0.45

)

Diluted

$

0.07

$

(0.25

)

$

(0.14

)

$

(0.45

)

Net income per common share from discontinued operations:

Basic

$

$

0.90

$

$

0.85

Diluted

$

$

0.90

$

$

0.85

Net income (loss) per common share:

Basic

$

0.07

$

0.65

$

(0.14

)

$

0.40

Diluted

$

0.07

$

0.65

$

(0.14

)

$

0.40

Weighted average shares outstanding:

Basic

9,047

9,751

9,232

9,913

Diluted

9,114

9,751

9,232

9,913

Adjusted EBITDA 1

$

1,451

$

(335

)

$

489

$

(802

)

1We define "EBITDA" as earnings before interest, income taxes, depreciation and amortization. We define "Adjusted EBITDA" as EBITDA further adjusted for the impact of non-cash and other items we do not consider in our evaluation of ongoing performance. These items include: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, shelf registration costs, loss on extinguishment of debt, retention costs and restructuring and severance costs from net income. We caution investors that amounts presented in accordance with our definitions of EBITDA and Adjusted EBITDA may not be comparable to similar measures disclosed by other companies because not all companies calculate EBITDA and Adjusted EBITDA in the same manner. We present EBITDA and Adjusted EBITDA because we consider them to be important supplemental measures of our performance and investors' understanding of our performance is enhanced by including these non-GAAP financial measures as a reasonable basis for comparing our ongoing results of operations.

Ascent Industries Co.

Consolidated Statements of Cash Flows

($ in thousands)

(Unaudited)

Six Months Ended June 30,

2026

2025

Cash flows from operating activities:

Net income (loss)

$

(1,310

)

$

3,993

Income from discontinued operations, net of tax

8,446

Net loss from continuing operations

(1,310

)

(4,453

)

Adjustments to reconcile net income (loss) to net cash used in operating activities:

Depreciation expense

1,737

1,870

Amortization expense

490

306

Amortization of debt issuance costs

100

179

Asset impairments

1,622

Deferred income taxes

(487

)

(90

)

Reduction of losses on accounts receivable

(961

)

(506

)

Non-cash lease expense

(51

)

(1

)

Stock-based compensation expense

366

222

Changes in operating assets and liabilities:

Accounts receivable and advances

(6,458

)

(4,908

)

Inventories

(1,134

)

(939

)

Other assets and liabilities

(783

)

(1,937

)

Accounts payable

2,584

(1,712

)

Accrued expenses

(2,006

)

1,387

Accrued income taxes

189

19

Net cash used in operating activities - continuing operations

(7,724

)

(8,941

)

Net cash provided by operating activities - discontinued operations

6,845

Net cash used in operating activities

(7,724

)

(2,096

)

Cash flows from investing activities:

Purchases of property, plant and equipment

(1,176

)

(466

)

Acquisitions, net of cash acquired

(13,536

)

Net cash used in investing activities - continuing operations

(14,712

)

(466

)

Net cash provided by investing activities - discontinued operations

54,425

Net cash provided by (used in) investing activities

(14,712

)

53,959

Cash flows from financing activities:

Borrowings from credit facilities

54,850

89,670

Proceeds from note payable

997

1,085

Proceeds from exercise of stock options

398

Payments on credit facilities

(54,850

)

(89,670

)

Payments on note payable

(433

)

(370

)

Principal payments on finance lease obligations

(163

)

(144

)

Repurchase of common stock

(6,850

)

(8,044

)

Net cash used in financing activities - continuing operations

(6,051

)

(7,473

)

Net cash used in financing activities - discontinued operations

(19

)

Net cash used in financing activities

(6,051

)

(7,492

)

Increase (decrease) in cash, cash equivalents and restricted cash

(28,487

)

44,371

Cash, cash equivalents and restricted cash, beginning of period

57,606

16,108

Cash, cash equivalents and restricted cash, end of period

$

29,119

$

60,479

Ascent Industries Co.

Non-GAAP Financial Measures Reconciliation

Reconciliation of Net Income (Loss) to Adjusted EBITDA

($ in thousands)

(Unaudited)

(Unaudited)

Three Months Ended

June 30,

Six Months Ended

June 30,

($ in thousands)

2026

2025

2026

2025

Consolidated

Net income (loss) from continuing operations

$

670

$

(2,447

)

$

(1,310

)

$

(4,453

)

Adjustments:

Interest (income) expense, net

(155

)

(15

)

(448

)

99

Income taxes

(601

)

(89

)

(487

)

(89

)

Depreciation

877

893

1,737

1,870

Amortization

373

153

490

306

EBITDA

1,164

(1,505

)

(18

)

(2,267

)

Acquisition costs and other

176

31

177

268

Shelf registration costs

14

Asset impairments

1,622

1,622

Gain on lease modification

(544

)

(544

)

Stock-based compensation

137

86

270

120

Non-cash lease expense

(26

)

(25

)

(51

)

(1

)

Restructuring and severance costs

97

Adjusted EBITDA

$

1,451

$

(335

)

$

489

$

(802

)

% sales

5.7

%

(1.8

)%

1.1

%

(2.2

)%

Specialty Chemicals

Net income (loss)

$

656

$

1,499

$

(1,486

)

$

2,237

Adjustments:

Interest expense, net

13

15

25

32

Depreciation

835

878

1,652

1,840

Amortization

373

153

490

306

EBITDA

1,877

2,545

681

4,415

Acquisition costs and other

92

Stock-based compensation

24

54

Non-cash lease expense

(15

)

(5

)

(30

)

3

Restructuring and severance costs

38

Specialty Chemicals Adjusted EBITDA

$

1,886

$

2,540

$

743

$

4,510

% segment sales

7.3

%

13.6

%

1.6

%

12.4

%